S 5459
Biosimilars Access and Affordability Act
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
The Biosimilars Access and Affordability Act aims to increase access to and lower the cost of biosimilar biological products by modifying how they are eligible for price negotiations under Medicare. Specifically, it changes the criteria for when a biosimilar can be included on the list of selected drugs for price negotiation, shifting the focus to a manufacturer’s demonstrated intent to market the product. The bill also introduces a delay mechanism for manufacturers seeking to negotiate prices, and establishes a rebate system if a biosimilar doesn't become available within a specified timeframe.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.